Authors: NOONAN MJ CHERVINSKY P WOLFE J LIDDLE R KELLERMAN DJ CRESCENZI KL

Citation: Mj. Noonan et al., DOSE-RELATED RESPONSE TO INHALED FLUTICASONE PROPIONATE IN PATIENTS WITH METHACHOLINE-INDUCED BRONCHIAL HYPERRESPONSIVENESS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, The Journal of asthma, 35(2), 1998, pp. 153-164

Authors: PEARLMAN DS NOONAN MJ TASHKIN DP GOLDSTEIN MF HAMEDANI AG KELLERMAN DJ SCHABERG A

Citation: Ds. Pearlman et al., COMPARATIVE EFFICACY AND SAFETY OF TWICE-DAILY FLUTICASONE PROPIONATEPOWDER VERSUS PLACEBO IN THE TREATMENT OF MODERATE ASTHMA, Annals of allergy, asthma, & immunology, 78(4), 1997, pp. 356-362

Authors: GALANT SP LAWRENCE M MELTZER EO TOMASKO M BAKER KA KELLERMAN DJ

Citation: Sp. Galant et al., FLUTICASONE PROPIONATE COMPARED WITH THEOPHYLLINE FOR MILD-TO-MODERATE ASTHMA, Annals of allergy, asthma, & immunology, 77(2), 1996, pp. 112-118

Authors: OKAMOTO LJ NOONAN M DEBOISBLANC BP KELLERMAN DJ

Citation: Lj. Okamoto et al., FLUTICASONE PROPIONATE IMPROVES QUALITY-OF-LIFE IN PATIENTS WITH ASTHMA REQUIRING ORAL CORTICOSTEROIDS, Annals of allergy, asthma, & immunology, 76(5), 1996, pp. 455-461

Authors: WASSERMAN SI GROSS GN SCHOENWETTER WF MUNK ZM KRAL KM SCHABERG A KELLERMAN DJ

Citation: Si. Wasserman et al., A 12-WEEK DOSE-RANGING STUDY OF FLUTICASONE PROPIONATE POWDER IN THE TREATMENT OF ASTHMA, The Journal of asthma, 33(4), 1996, pp. 265-274

Authors: NOONAN MJ MUNK ZM CHERVINSKY P DOCKHORN RJ PINNAS J WOLFE J CRESCENZI KL KELLERMAN DJ

Citation: Mj. Noonan et al., LOW-DOSES OF INHALED FLUTICASONE PROPIONATE (FP) REDUCE BRONCHIAL HYPERRESPONSIVENESS (BHR), Journal of allergy and clinical immunology, 97(1), 1996, pp. 273-273